NEW YORK, Apr 22, 2022 - (ACN Newswire) - Beyond Imagination, Inc. is building humanoid robots to solve the world's labor crisis by expanding access to jobs around the globe.
This week, the Beomni robot will appear at Explorers Club Headquarters and at the annual dinner on Saturday April 23rd in New York City. At the same time, across the country in Beverly Hills, CA, attendees at the Abundance360 Annual Summit will be able to remotely pilot the robot from 2,800 miles away.
Beomni is the world's most sophisticated general-purpose humanoid robot, capable of performing an almost unlimited number of tasks. Beomni's AI Brain learns from its human pilots and becomes increasingly autonomous over time.
Beomni will help solve the labor crisis by creating a global elastic labor force, lifting millions of people out of poverty by giving them access to jobs around the world. For example, the International Labour Organization (ILO) reports that "More than 2.3 million workers die every year as a result of occupational accidents or work-related diseases." With Beomni, dangerous work will become completely safe because the robot will be the one taking the risks.
Elder Care is a $932B market today. We will help solve the elder crisis by enabling families to care for their own regardless of the distance between them and by multiplying the effectiveness of existing health care workers.
CEO and Founder Dr. Harry Kloor says, "We are thrilled to have been invited to demonstrate the advances we've made in Beomni's development at the Explorers Club. Beomni will be a great vehicle for explorers on earth and beyond! We share the spirit of exploration and discovery that is the hallmark of the Explorers Club."
Astronaut and Explorers Club President Richard Garriott adds, "For the last decade, I have been a power USER of early telepresence robotics devices, so I deeply appreciate the advancements in Beomni. We welcome the opportunity to showcase Dr. Kloor's creation alongside other world-changing technologies at our event. Smart technologies like Beomni will play an important part in helping solve the challenges the world is facing. On Earth, in space and on planets beyond Earth, robots like Beomni will play an essential role!"
The robot will be on display all week at the Explorers Club headquarters so members can have an opportunity to pilot it. On Saturday, Beomni will move to The Glass House, where the annual dinner is being held. Beomni will be serving drinks and hors d'oeuvres at the reception, and at the afterparty guests will also have the opportunity to pilot the robot.
Meanwhile, across the country in Beverly Hills, a second Beyond Imagination team will be set up at the Abundance360 Annual Summit. From there, Beomni will be operated from coast to coast. Members in attendance at the A360 Summit will be able to perform tasks, pick up and examine objects and even shake someone's hand across the country.
Abundance360 Founder, Peter Diamandis remarked, "Beyond Imagination dramatically changes the paradigm of how companies will provide services in the future, how and where you will receive healthcare, where you work and play."
About Beyond Imagination, Inc.
Beyond Imagination is a robotics and AI platform company that is focused on bringing humanoid robots to market rapidly. By partnering a human pilot with an evolving AI Brain, we will soon be able to deploy our Beomni Robotics platform across a wide range of commercial applications. Our practical, real-world approach is closer to that of Tesla, which released its vehicles and then built AI from the data that they collected, rather than that of other companies that are focused on narrow R&D domains.
Founded by leading innovators in AI and robotics, and strengthened by a solid patent portfolio, Beyond Imagination, Inc. is poised to revolutionize life and fundamentally change the way we work, travel and engage with others around the world.
Beyond Imagination is actively seeking business partners and investors for its Series A round. Details will be provided to qualified investors upon request. In-person demos are available by appointment for media and investors. Beyond Imagination is also seeking additional partners for pilot studies in medicine and beyond.
About The Explorers Club
Since its inception in 1904, members of the Club have traversed the earth, the seas, the skies, and even the moon, on expeditions. First to the North Pole, first to the South Pole, first to the summit of Mount Everest, first to the deepest point in the ocean and first to the surface of the moon - all accomplished by Explorers Club Members. Notable members include Teddy Roosevelt, Neil Armstrong, Jane Goodall, Edmund Hillary, John Glenn, Sally Ride, Bob Ballard, and more. https://www.explorers.org/
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comBeyond Imagination, Inc. is building humanoid robots to solve the world's labor crisis by expanding access to jobs around the globe.
ADELAIDE, AUS, Apr 19, 2022 - (ACN Newswire) - Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.
Avance Clinical has undergone significant expansion in recent years, including new offices in Sydney and Melbourne to accommodate the growing clinical team in Australia.
The award winner will be announced on 1 September 2022. The finalists are: - Avance Clinical - Calyx - CMIC Group - EPS - ICON - Parexel - Syneos Health
Avance Clinical's CEO Yvonne Lungershausen said:
"Avance Clinical is extremely pleased to be selected as a finalist for this prestigious award. It is a credit to our amazing customer-focused team for delivering the CRO excellence that has been recognized by the Informa Pharma Intelligence award judges.
"Avance Clinical has a global reputation for agile clinical solutions to support accelerated clinical development for our international biotech clients. We are very proud of our growth and success in APAC in recent years."
According to Informa Pharma Intelligence:
This Award is to recognize CROs that provide full or specialist services to their clients and which have an office in either in Japan or the Asia region including Australia.
Judging considers the quality of services and relationships built with clients and pays particular attention to the innovative patient recruitment strategies the CRO has brought to the table.
The award is based on achievements in the 2021 calendar year.
Core areas judged include: - The particular capabilities and strengths the CRO offers - How the company has delivered results that exceed sponsor expectations - Innovations in patient recruitment strategy has the CRO brought to its partner - How it has improved its performance, for example, in its quality of data, timelines and transparency - The steps the company is taking towards streamlining data collection and reporting
Avance Clinical recently secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m.
"With the support of Riverside and its powerful global footprint and deep healthcare experience, Avance Clinical will execute on its regional and international expansion plans organically and via acquisitions," said Lungershausen.
Avance Clinical is the Australian-owned CRO that provides global regulatory standard clinical research services across all phases to the local and international biopharma industry.
The company is also accredited as a gene technology CRO under the Office of the Gene Technology Regulator (OGTR) which has allowed it to expand into clinical trials for vaccines and GMO therapies.
"We have shown, with our high growth and industry-leading repeat business rates that our focus on gold standard technology paired with solution-orientated clinical experts is the mix our biopharma clients require in this fast-moving, competitive and high-stakes sector," said Lungershausen.
Avance Clinical has been recognised for the past two consecutive years with the prestigious Frost & Sullivan CRO Best Practices Award.
Avance Clinical is the largest premium full-service Australian CRO delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs. The company's clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.
Frost & Sullivan Awards Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past two years, has been providing CRO services in the region for 24 years.
Pre-clinical through to Phase 1 and 2 Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phase 1 and 2 clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.
With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.
Technology Avance Clinical uses state-of-the-art technology and gold standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.
Several bitcoin futures exchange-traded funds are now trading in the U.S, with more to come. For example, SEC approved the Teucrium Bitcoin Futures ETF earlier this month, filed under the Securities Act of 1933. Also, other Bitcoin Futures ETFs approved over the last year were approved under the Investment Company Act of 1940. But a spot […]
The Parliament of the EU has designated ESMA, the European Securities and Markets Authority, the top cryptocurrency regulator of the region in the latest draft of MiCA, the Markets in Crypto Assets regulation. The European organization would have the task of licensing crypto-related institutions and exchanges, putting national regulators under its authority. ESMA Gets Crypto […]
How Is Crypto Taxed in the United States? It’s important for investors, including those with cryptocurrency IRAs, to understand how taxes affect their accounts. Cryptocurrencies are treated as property according to the IRS, just like many other investments. Every sale may cause a taxable event, with only a few exceptions. But if you hold your […]